Medicament for atrophy treatment or increasing cell growth
AssigneeSimu Trade Consulting GmbH & Co. Leasing KG
InventorRudolf Berger
Life of this patent
Estimating the term…
Abstract
The present invention provides SERF2, a nucleic acid encoding said SERF2 or a cell expressing SERF2 for use as a medicament, in particular for use for use in treating or preventing an atrophy disease or condition or for increasing cellular growth in a patient such as sarcopenia, cachexia, dystrophy, hypoplasia, hypotonia, or muscle loss, as well as in vitro methods suitable for cell culture proliferation and pharmaceutical compositions.
Claims20
A medicament comprising SERF2, a nucleic acid encoding said SERF2 or a cell expressing SERF2.
A method of treating or preventing an atrophy disease or condition in a patient or method for cell regenerative therapy in a patient comprising the administration of SERF2, a nucleic acid encoding said SERF2 or a cell expressing SERF2 to the patient.
A method of increasing the proliferation of stem cells, progenitor cells, epithelial cells, in particular epider-mal skin cells, mesenchymal cells, in particular cardiomyocytes, satellite cells, skeletal muscle cells, hematopoietic cells, in particular hematopoietic stem cells or progenitor cells, or re-ducing the rate of apoptosis of said cells, comprising admin-istration of SERF2 or SERF2 encoding nucleic acids to said cells.
A pharmaceutical composition comprising SERF2 or SERF2 encoding nucleic acids and a pharmaceutically acceptable diluent, carrier, solubilizer, emulsifier, preservative, stabilizer and/or adjuvant.
Dependencies are inferred from the claim text.